Month: August 2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to […]

Read More

Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials

Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon, marking a new era of […]

Read More

QFBA, Education Above All Sign Cooperation Agreement

Qatar Finance and Business Academy (QFBA) has signed a cooperation agreement with Education Above All Foundation to provide educational opportunities for underprivileged students of both genders. The agreement aims to offer scholarships through the Qa…

Read More

Qatar Stock Exchange Index Rises by 1.32 Percent

Qatar Stock Exchange (QSE) general index rose by 145.050 points (1.320 percent), to close at 11,108 points, on Tuesday.A total of 195,939,64 shares were traded, with a value of QR 572,463,929.565 from 19,583 transactions in all sectors.Of the listed c…

Read More